Clal Biotechnology Industries Ltd. (CBI.TA)
Tel Aviv · ILA · Healthcare · Biotechnology
ILA 21.50 (-0.46%) as of
Key statistics
- Market cap
- 33.72M
- EPS (TTM)
- -0.06
- Dividend yield
- 0.00%
- 52-week range
- 20.60 – 36.00
- Beta
- 0.34
- Revenue (TTM)
- -118k
- Profit margin
- 0.00%
- Volume
- 308.83k
About Clal Biotechnology Industries Ltd.
Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It takes a seat on the board of directors of the companies it invests in. It invests through personal capital of its management. The firm acts as a lead investor and major shareholder in its portfolio companies. Clal Biotechnology Industries Ltd. was founded in July, 1998 and is based in Tel Aviv, Israel. It operates as a former subsidiary of Clal Industries and Investments Ltd.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Tel Aviv, Israel
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.